H A Valantine
Overview
Explore the profile of H A Valantine including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
718
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stevenson D, Shaw G, Wise P, Norton M, Druzin M, Valantine H, et al.
J Perinatol
. 2012 Oct;
33(4):251-8.
PMID: 23079774
Medical researchers have called for new forms of translational science that can solve complex medical problems. Mainstream science has made complementary calls for heterogeneous teams of collaborators who conduct transdisciplinary...
2.
Kuppahally S, Valantine H, Weisshaar D, Parekh H, Hung Y, Haddad F, et al.
Am J Transplant
. 2007 Sep;
7(10):2388-95.
PMID: 17845572
The ongoing shortage of donors for cardiac transplantation has led to a trend toward acceptance of donor hearts with some structural abnormalities including left ventricular hypertrophy. To evaluate the outcome...
3.
Kobashigawa J, Tobis J, Mentzer R, Valantine H, Bourge R, Mehra M, et al.
Am J Transplant
. 2006 Apr;
6(5 Pt 1):993-7.
PMID: 16611335
Unlabelled: The mycophenolate mofetil (MMF) trial involved 650 heart transplant patients from 28 centers who received MMF or azathioprine (AZA), both in combination with cyclosporine and corticosteroids. Baseline and 1-year...
4.
Kuppahally S, Al-Khaldi A, Weisshaar D, Valantine H, Oyer P, Robbins R, et al.
Am J Transplant
. 2006 Apr;
6(5 Pt 1):986-92.
PMID: 16611334
Sirolimus was introduced in de novo immunosuppression at Stanford University in view of its favorable effects on reduced rejection and cardiac allograft vasculopathy. After an apparent increase in the incidence...
5.
Chan M, Kwok B, Shiba N, Cantin B, Valantine H, Hunt S
Transplant Proc
. 2002 Aug;
34(5):1850-2.
PMID: 12176601
No abstract available.
6.
Clark L, Ferdinand K, Flack J, Gavin 3rd J, Hall W, Kumanyika S, et al.
Heart Dis
. 2002 Apr;
3(2):97-108.
PMID: 11975778
African Americans have the highest overall mortality rate from coronary heart disease (CHD) of any ethnic group in the United States, particularly out-of-hospital deaths, and especially at younger ages. Although...
7.
Blankenberg F, Wen P, Dai M, Zhu D, Panchal S, Tait J, et al.
Pediatr Radiol
. 2001 Dec;
31(12):827-35.
PMID: 11727015
Background: Migration of monocytes into the arterial wall is an early finding of atherosclerosis. Monocytes are attracted to sites of vascular endothelial cell injury, the initiating event in the development...
8.
Valantine H, Luikart H, Doyle R, Theodore J, Hunt S, Oyer P, et al.
Transplantation
. 2001 Dec;
72(10):1647-52.
PMID: 11726825
Background: Cytomegalovirus (CMV) disease was previously shown to be unaltered by a 28-day course of ganciclovir compared with placebo in seronegative recipients of hearts from seropositive donors (D+/R-). This study...
9.
Cantin B, Wen P, Zhu D, Dai M, Panchal S, Billingham M, et al.
Circulation
. 2001 Nov;
104(21):2615-9.
PMID: 11714659
Background: Allograft coronary atherosclerosis (TxCAD) is the leading cause of death after the first year after transplantation. TxCAD is believed to be a form of chronic rejection of the cardiac...
10.
Giannetti N, Herity N, Alimollah A, Gao S, Schroeder J, Yeung A, et al.
Clin Transplant
. 2001 Oct;
15(4):247-52.
PMID: 11683818
Background: Hyperhomocysteinemia is an independent risk factor for coronary disease and elevated plasma homocysteine levels have been documented in heart transplant recipients. The aim of this study was to test...